文献速递儿童内分泌与遗传代谢儿童消化与营养

超重与肥胖儿童及青少年的骨龄、预测成年身高与HOMA-IR:单中心横断面研究

Bone age, predicted adult height and HOMA-IR in children and adolescents with overweight and obesity: a single-centre cross-sectional study
RSS 订阅 · BMJ Paediatrics Open

该单中心横断面研究纳入130名5–15岁中国超重或肥胖男童,记录身高、体重、BMI、骨龄(BA)、预测成年身高(PAH)及稳态模型评估胰岛素抵抗指数(HOMA-IR)。结果显示骨龄中位数显著高于实际年龄,PAH显著低于父母中位身高,骨龄提前、PAH受损及胰岛素抵抗发生率分别为52.3%、22.6%和61.3%;骨龄提前和HOMA-IR与BMI z评分正相关,BMI z评分>2.40 SDS可能提示骨龄提前和胰岛素抵抗。

要点

  • 超重/肥胖男童中约半数存在骨龄提前,近三分之二存在胰岛素抵抗。
  • 骨龄提前和HOMA-IR均与BMI z评分呈正相关。
  • BMI z评分>2.40 SDS或可提示骨龄提前和胰岛素抵抗。

核心结论

  • 约半数超重/肥胖男童存在骨龄提前,五分之一存在PAH受损,三分之二存在胰岛素抵抗。
  • 骨龄提前和HOMA-IR与BMI z评分正相关,BMI z评分>2.40 SDS可能提示骨龄提前和胰岛素抵抗。

研究设计与样本

  • 单中心横断面研究,纳入130名5–15岁中国超重或肥胖男童(超重43例,肥胖87例)。
  • 记录身高、体重、BMI、BA、PAH和HOMA-IR,采用Spearman秩相关和ROC曲线分析。

主要发现

  • 骨龄中位数12.00(IQR 11.00–13.00)显著高于实际年龄10.67(IQR 9.50–12.00),p=0.000。
  • PAH显著低于父母中位身高:–0.28±0.81 versus 0.10±0.60,p=0.000。
  • 骨龄提前、PAH受损和胰岛素抵抗的患病率分别为52.3%(67/128)、22.6%(28/124)和61.3%(49/80)。
  • 骨龄提前与BMI z评分正相关(rs=0.495,p=0.000),HOMA-IR与BMI z评分正相关(rs=0.343,p=0.002)。
  • PAH受损与BMI z评分无显著关联(rs=0.045,p=0.622)。

关键数值与推荐

  • BMI z评分诊断骨龄提前的ROC曲线下面积为0.741。
  • BMI z评分诊断胰岛素抵抗的ROC曲线下面积为0.622。
  • 以BMI z评分2.40 SDS为界值,诊断骨龄提前的敏感度0.567、特异度0.820。
  • 以BMI z评分2.40 SDS为界值,诊断胰岛素抵抗的敏感度0.571、特异度0.645。

临床怎么用

  • 对超重/肥胖男童应关注骨龄和胰岛素抵抗的评估。
  • BMI z评分>2.40 SDS时可考虑筛查骨龄提前和胰岛素抵抗。

局限性

  • 单中心横断面设计,仅纳入中国5–15岁超重或肥胖男童,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background We aimed to investigate the effects of overweight and obesity on bone age (BA), predicted adult height (PAH) and glucose metabolism in children and adolescents. Methods Chinese boys aged 5–15 years who were overweight or obese were recruited for the study. Clinical characteristics, including height, weight, body mass index (BMI), BA, PAH and homeostatic model assessment of insulin resistance (HOMA-IR), were recorded. Spearman’s rank-order correlation was used to analyse associations between BA, PAH, HOMA-IR and BMI z-scores. Receiver-operating characteristic (ROC) curves were generated to evaluate the diagnostic value of the BMI z-score. Results Data from 130 males (n=43, overweight; n=87, obese) were collected. The median BA of the cohort was significantly higher than the chronological age: 12.00 (IQR: 11.00 to 13.00) versus 10.67 (IQR: 9.50 to 12.00; p=0.000). PAH was significantly lower than mid-parental height: –0.28±0.81 versus 0.10±0.60 (p=0.000). The prevalence of BA advancement, PAH impairment and insulin resistance was 52.3% (67/128), 22.6% (28/124) and 61.3% (49/80), respectively. BA advancement and HOMA-IR positively correlated with BMI z-score (Spearman’s coefficients r s =0.495, p=0.000 and r s =0.343, p=0.002, respectively). No significant association was found between PAH impairment and BMI z-score ( r s =0.045, p=0.622). The ROC curves showed that the area under the curve for the BMI z-score of BA advancement and insulin resistance was 0.741 and 0.622, respectively. The sensitivity and specificity for BA advancement with a cut-off of 2.40 SD score (SDS) were 0.567 and 0.820, and for insulin resistance with a cut-off of 2.40 SDS, were 0.571 and 0.645. Conclusions Approximately half of the included children had advanced BA, one-fifth of them had PAH impairment and two-thirds exhibited insulin resistance. Advanced BA and HOMA-IR were positively correlated with the BMI z-score. A BMI z-score above 2.40 SDS may indicate BA advancement and insulin resistance.

来源:BMJ Paediatrics Open,查看原文。版权归原作者所有。

引用

  1. BMJ Paediatrics Open:Bone age, predicted adult height and HOMA-IR in children and adolescents with overweight and obesity: a single-centre cross-sectional study

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。